Overcoming acquired osimertinib-resistance in EGFR-mutant advanced non-small lung cancer mediated by activating BRAF V600E mutation. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting ...
New research reveals a model to predict chronic immune thrombocytopenia in children at diagnosis. Learn how it could guide ...